Inhibition effect of cypermethrin mediated by co-regulators SRC-1 and SMRT in interleukin-6-induced androgen receptor activation

Chemosphere

Volumn 158, Issue , 2016, Pages 24-29

  Wang, Qi ^a   Zhou, Ji Long ^a   Wang, Hui ^a   Ju, Qiang ^a   Ding, Zhen ^a   Zhou, Xiao Long ^a   Ge, Xing ^a   Shi, Qiao Mei ^a   Pan, Chen ^a   Zhang, Jin Peng ^a   Zhang, Mei Rong ^a   Yu, Hong Min ^a   Xu, Li Chun ^a  

^a XUZHOU MEDICAL UNIVERSITY   (China)

Author keywords

Androgen receptor; Anti androgen; Cypermethrin; Interleukin 6; Silencing mediator for retinoid and thyroid hormone receptors; Steroid receptor co activator 1

Indexed keywords

CELL GROWTH; CELL PROLIFERATION; ENDOCRINOLOGY; GROWTH KINETICS; LIGANDS; MAMMALS; STEROID HORMONES;

ANDROGEN RECEPTORS; ANTI-ANDROGEN; COACTIVATORS; CYPERMETHRINS; INTERLEUKIN-6; THYROID HORMONE RECEPTOR;

IMMUNOLOGY;

ANDROGEN RECEPTOR; CYPERMETHRIN; INTERLEUKIN 6; SILENCING MEDIATOR OF RETINOID AND THYROID HORMONE RECEPTOR; STEROID RECEPTOR COACTIVATOR 1; ANDROGEN RECEPTOR ANTAGONIST; AR PROTEIN, HUMAN; IL6 PROTEIN, HUMAN; NCOA1 PROTEIN, HUMAN; NCOR2 PROTEIN, HUMAN; PYRETHROID;

ANDROGEN; ANTAGONISM; BIOASSAY; CELLS AND CELL COMPONENTS; CYPERMETHRIN; GENE; GROWTH RESPONSE; HORMONE; INHIBITOR; MAMMAL; STEROID;

ANIMAL CELL; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; GROWTH INHIBITION; HUMAN; HUMAN CELL; LNCAP CELL LINE; MALE; MOLECULAR INTERACTION; NONHUMAN; SIGNAL TRANSDUCTION; ANIMAL; CELL LINE; CHEMISTRY; CHLOROCEBUS AETHIOPS; METABOLISM; PROSTATE TUMOR; TUMOR CELL LINE; TWO HYBRID SYSTEM;

MAMMALIA;

ANDROGEN RECEPTOR ANTAGONISTS; ANIMALS; CELL LINE; CELL LINE, TUMOR; CERCOPITHECUS AETHIOPS; HUMANS; INTERLEUKIN-6; MALE; NUCLEAR RECEPTOR CO-REPRESSOR 2; NUCLEAR RECEPTOR COACTIVATOR 1; PROSTATIC NEOPLASMS; PYRETHRINS; RECEPTORS, ANDROGEN; TWO-HYBRID SYSTEM TECHNIQUES;

EID: 84969786203     PISSN: 00456535     EISSN: 18791298     Source Type: Journal    
DOI: 10.1016/j.chemosphere.2016.05.053     Document Type: Article

References (44)

1. Atienza J.M., Zhu J., Wang X., Xu X., Abassi Y. Dynamic monitoring of cell adhesion and spreading on microelectronic sensor arrays. J. Biomol. Screen. 2005, 10:795-805.
2. Azevedo A., Cunha V., Teixeira A.L., Medeiros R. IL-6/IL-6R as a potential key signaling pathway in prostate cancer development. World J. Clin. Oncol. 2011, 2:384-396.
3. Bain D.L., Heneghan A.F., Connaghan-Jones K.D., Miura M.T. Nuclear receptor structure: implications for function. Annu. Rev. Physiol. 2007, 69:201-220.
4. Bevan C.L., Hoare S., Claessens F., Heery D.M., Parker M.G. The AF1 and AF2 domains of the androgen receptor interact with distinct regions of SRC1. Mol. Cell. Biol. 1999, 19:8383-8392.
5. Brinkmann A.O., Blok L.J., de Ruiter P.E., Doesburg P., Steketee K., Berrevoets C.A., Trapman J. Mechanisms of androgen receptor activation and function. J. Steroid Biochem. Mol. Biol. 1999, 69:307-313.
6. Culig Z. Androgen receptor coactivators in regulation of growth and differentiation in prostate Cancer. J. Cell. Physiol. 2016, 231:270-274.
7. Culig Z., Klocker H., Bartsch G., Hobisch A. Androgen receptors in prostate cancer. Endoc. Relat. Cancer 2002, 9:155-170.
8. Dehm S.M., Tindall D.J. Ligand-independent androgen receptor activity is activation function-2-independent and resistant to antiandrogens in androgen refractory prostate cancer cells. J. Biol. Chem. 2006, 281:27882-27893.
9. Diamanti-Kandarakis E., Bourguignon J.P., Giudice L.C., Hauser R., Prins G.S., Soto A.M., Zoeller R.T., Gore A.C. Endocrine-disrupting chemicals: an Endocrine Society scientific statement. Endocr. Rev. 2009, 30:293-342.
10. Diamanti-Kandarakis E., Palioura E., Kandarakis S.A., Koutsilieris M. The impact of endocrine disruptors on endocrine targets. Horm. Metab. Res. 2010, 42:543-552.
11. Drachenberg D.E., Elgamal A.A., Rowbotham R., Peterson M., Murphy G.P. Circulating levels of interleukin-6 in patients with hormone refractory prostate cancer. Prostate 1999, 41:127-133.
12. Elbetieha A., Da'as S.I., Khamas W., Darmani H. Evaluation of the toxic potentials of cypermethrin pesticide on some reproductive and fertility parameters in the male rats. Arch. Environ. Contam. Toxicol. 2001, 41:522-528.
13. Glass C.K., Rosenfeld M.G. The coregulator exchange in transcriptional functions of nuclear receptors. Genes Dev. 2000, 14:121-141.
14. Gray L.E., Ostby J., Furr J., Wolf C.J., Lambright C., Parks L., Veeramachaneni D.N., Wilson V., Price M., Hotchkiss A., Orlando E., Guillette L. Effects of environmental antiandrogens on reproductive development in experimental animals. Hum. Reprod. Update 2001, 7:248-264.
15. Guenther M.G., Barak O., Lazar M.A. The SMRT and N-CoR corepressors are activating cofactors for histone deacetylase 3. Mol. Cell. Biol. 2001, 21:6091-6101.
16. Heemers H.V., Tindall D.J. Androgen receptor (AR) coregulators: a diversity of functions converging on and regulating the AR transcriptional complex. Endocr. Rev. 2007, 28:778-808.
17. Hodgson M.C., Astapova I., Hollenberg A.N., Balk S.P. Activity of androgen receptor antagonist bicalutamide in prostate cancer cells is independent of NCoR and SMRT corepressors. Cancer Res. 2007, 67:8388-8395.
18. Hsu C.L., Chen Y.L., Ting H.J., Lin W.J., Yang Z., Zhang Y., Wang L., Wu C.T., Chang H.C., Yeh S., Pimplikar S.W., Chang C. Androgen receptor (AR) NH2- and COOH-terminal interactions result in the differential influences on the AR-mediated transactivation and cell growth. Mol. Endocrinol. 2005, 19:350-361.
19. Hu J.X., Li Y.F., Pan C., Zhang J.P., Wang H.M., Li J., Xu L.C. Anti-androgen effects of cypermethrin on the amino- and carboxyl-terminal interaction of the androgen receptor. Toxicology 2012, 292:99-104.
20. Jenster G. Ligand-independent activation of the androgen receptor in prostate cancer by growth factors and cytokines. J. Pathology 2000, 191:227-228.
21. Ke N., Wang X., Xu X., Abassi Y.A. The xCELLigence system for real-time and label-free monitoring of cell viability. Methods Mol. Biol. 2011, 740:33-43.
22. Lee S.O., Lou W., Hou M., de Miguel F., Gerber L., Gao A.C. Interleukin-6 promotes androgen-independent growth in LNCaP human prostate cancer cells. Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res. 2003, 9:370-376.
23. Liao G., Chen L.Y., Zhang A., Godavarthy A., Xia F., Ghosh J.C., Li H., Chen J.D. Regulation of androgen receptor activity by the nuclear receptor corepressor SMRT. J. Biol. Chem. 2003, 278:5052-5061.
24. Lin D.L., Whitney M.C., Yao Z., Keller E.T. Interleukin-6 induces androgen responsiveness in prostate cancer cells through up-regulation of androgen receptor expression. Clin. cancer Res. Off. J. Am. Assoc. Cancer Res. 2001, 7:1773-1781.
25. Lonergan P.E., Tindall D.J. Androgen receptor signaling in prostate cancer development and progression. J. Carcinog. 2011, 10:20.
26. Lou W., Ni Z., Dyer K., Tweardy D.J., Gao A.C. Interleukin-6 induces prostate cancer cell growth accompanied by activation of stat3 signaling pathway. Prostate 2000, 42:239-242.
27. Malinowska K., Neuwirt H., Cavarretta I.T., Bektic J., Steiner H., Dietrich H., Moser P.L., Fuchs D., Hobisch A., Culig Z. Interleukin-6 stimulation of growth of prostate cancer in vitro and in vivo through activation of the androgen receptor. Endocr. Relat. Cancer 2009, 16:155-169.
28. McKenna N.J., O'Malley B.W. Combinatorial control of gene expression by nuclear receptors and coregulators. Cell 2002, 108:465-474.
29. Mellado B., Codony J., Ribal M.J., Visa L., Gascon P. Molecular biology of androgen-independent prostate cancer: the role of the androgen receptor pathway. Clin. Transl. Oncol. Off. Publ. Fed. Span. Oncol. Soc. Natl. Cancer Inst. Mexico 2009, 11:5-10.
30. Osguthorpe D.J., Hagler A.T. Mechanism of androgen receptor antagonism by bicalutamide in the treatment of prostate cancer. Biochemistry 2011, 50:4105-4113.
31. Pan C., Liu Y.P., Li Y.F., Hu J.X., Zhang J.P., Wang H.M., Li J., Xu L.C. Effects of cypermethrin on the ligand-independent interaction between androgen receptor and steroid receptor coactivator-1. Toxicology 2012, 299:160-164.
32. Pan C., Wang Q., Liu Y.P., Xu L.F., Li Y.F., Hu J.X., Jiang M., Zhang J.P., Zhang M.R., Yu H.M., Zhou J.L., Zhou X.L., Xu L.C. Anti-androgen effects of the pyrethroid pesticide cypermethrin on interactions of androgen receptor with corepressors. Toxicology 2013, 311:178-183.
33. Peng B., Wang S.Q., Zhao H.J., Weng Z.L. Inhibition of SRC-1 expression in prostate cancer cells by RNAi and its significance. Natl. J. Androl. 2011, 17:805-808. (in Chinese).
34. Prakash N., Vijay K.M., Sunilchandra U., Pavithra B., Pawar A. Evaluation of testicular toxicity following short-term exposure to cypermethrin in albino mice. Toxicol. Int. 2010, 17:18-21.
35. Singh P.B., Singh V. Cypermethrin induced histological changes in gonadotrophic cells, liver, gonads, plasma levels of estradiol-17beta and 11-ketotestosterone, and sperm motility in Heteropneustes fossilis (Bloch). Chemosphere 2008, 72:422-431.
36. Song L.N., Coghlan M., Gelmann E.P. Antiandrogen effects of mifepristone on coactivator and corepressor interactions with the androgen receptor. Mol. Endocrinol. 2004, 18:70-85.
37. Tien J.C., Zhou S., Xu J. The role of SRC-1 in murine prostate cancinogenesis is nonessential due to a possible compensation of SRC-3/AIB1 overexpression. Int. J. Biol. Sci. 2009, 5:256-264.
38. Ueda T., Mawji N.R., Bruchovsky N., Sadar M.D. Ligand-independent activation of the androgen receptor by interleukin-6 and the role of steroid receptor coactivator-1 in prostate cancer cells. J. Biol. Chem. 2002, 277:38087-38094.
39. Wang L.H., Yang X.Y., Zhang X., Huang J., Hou J., Li J., Xiong H., Mihalic K., Zhu H., Xiao W., Farrar W.L. Transcriptional inactivation of STAT3 by PPARgamma suppresses IL-6-responsive multiple myeloma cells. Immunity 2004, 20:205-218.
40. Wang Q., Xu L.F., Zhou J.L., Zhou X.L., Wang H., Ju Q., Pan C., Zhang J.P., Zhang M.R., Yu H.M., Xu L.C. Antagonism effects of cypermethrin on interleukin-6-induced androgen receptor activation. Environ. Toxicol. Pharmacol. 2015, 40:172-174.
41. Xu L.C., Liu L., Ren X.M., Zhang M.R., Cong N., Xu A.Q., Shao J.H. Evaluation of androgen receptor transcriptional activities of some pesticides in vitro. Toxicology 2008, 243:59-65.
42. Xu L.C., Sun H., Chen J.F., Bian Q., Song L., Wang X.R. Androgen receptor activities of p,p'-DDE, fenvalerate and phoxim detected by androgen receptor reporter gene assay. Toxicol. Lett. 2006, 160:151-157.
43. Yasunaga R., Ikuta J., Murata Y., Inoue K., Koga H., Masaki T., Tamura H. Ligand-independent androgen receptor antagonism caused by the newly developed pesticide pyrifluquinazon (PFQ). Reprod. Toxicol. 2013, 35:1-6.
44. Yoon H.G., Wong J. The corepressors silencing mediator of retinoid and thyroid hormone receptor and nuclear receptor corepressor are involved in agonist- and antagonist-regulated transcription by androgen receptor. Mol. Endocrinol. 2006, 20:1048-1060.